The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary arterial hypertension
Publications
Methamphetamine-associated pulmonary arterial hypertension.
Current opinion in pulmonary medicine 2022 Sep 01;28;352-360 — 2022 Sep 01 — 352-360
Methamphetamine and the risk of pulmonary arterial hypertension.
Current opinion in pulmonary medicine 2018 09;24;416-424 — 2018 09 — 416-424
Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead.
International journal of clinical practice. Supplement 2011 Jan;;8-10 — 2011 Jan — 8-10
Pulmonary arterial hypertension seen in methamphetamine abusers.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2008 Jun 15;65;1109-10 — 2008 Jun 15 — 1109-10
Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?
Chest 2006 Dec;130;1657-63 — 2006 Dec — 1657-63
Methamphetamine and the expanding complications of amphetamines.
The Western journal of medicine 1999 Apr;170;214-9 — 1999 Apr — 214-9
Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine.
Chest 1993 Aug;104;614-6 — 1993 Aug — 614-6